About

Eli Lilly Logo

Tirzepatide Once Weekly for the Treatment of Obesity

FDA approves subcutaneous tirzepatide injection (Mounjaro™) for Type 2 Diabetes

New Ozempic Dose Approved by FDA

Steering Committee